Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junko Murai

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing SarcomaSai-Wen Tang, Sven Bilke, Liang Cao, et al.
Oncogene|July 3, 2024
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forksHiroshi Onji, Sota Tate, Tomohisa Sakaue, et al.
DNA Repair|May 6, 2014
Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platformJunko Murai, Christophe Marchand, Sampada A Shahane, et al.
Plos One|January 29, 2021
Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell developmentFumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, et al.
Nucleic Acids Research|May 18, 2016
In vivo evidence for translesion synthesis by the replicative DNA polymerase δKouji Hirota, Masataka Tsuda, Mohiuddin, et al.
BMC Cancer|November 21, 2020
The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapyTakuma Kagami, Mihoko Yamade, Takahiro Suzuki, et al.
Cancer Science|November 22, 2021
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapyDaiki Taniyama, Naoya Sakamoto, Tsuyoshi Takashima, et al.
Journal of Clinical Medicine|October 14, 2022
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate-Case ReportYoshihiro Mouri, Manabu Natsumeda, Noritaka Okubo, et al.
Cancer Science|July 1, 2025
KLHL5 Contributes to Colorectal Cancer Cell Survival by Promoting Cell Cycle Progression and Suppressing Apoptotic Cell DeathKyosuke Habu, Yosuke Matsuoka, Hiromi Hiyoshi, et al.
Molecular Cell|February 4, 2018
SLFN11 Blocks Stressed Replication Forks Independently of ATRJunko Murai, Sai-Wen Tang, Elisabetta Leo, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing SarcomaSai-Wen Tang, Sven Bilke, Liang Cao, et al.
Oncogene|July 3, 2024
Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forksHiroshi Onji, Sota Tate, Tomohisa Sakaue, et al.
DNA Repair|May 6, 2014
Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platformJunko Murai, Christophe Marchand, Sampada A Shahane, et al.
Plos One|January 29, 2021
Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell developmentFumiya Moribe, Momoko Nishikori, Tsuyoshi Takashima, et al.
Nucleic Acids Research|May 18, 2016
In vivo evidence for translesion synthesis by the replicative DNA polymerase δKouji Hirota, Masataka Tsuda, Mohiuddin, et al.
BMC Cancer|November 21, 2020
The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapyTakuma Kagami, Mihoko Yamade, Takahiro Suzuki, et al.
Cancer Science|November 22, 2021
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapyDaiki Taniyama, Naoya Sakamoto, Tsuyoshi Takashima, et al.
Journal of Clinical Medicine|October 14, 2022
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate-Case ReportYoshihiro Mouri, Manabu Natsumeda, Noritaka Okubo, et al.
Cancer Science|July 1, 2025
KLHL5 Contributes to Colorectal Cancer Cell Survival by Promoting Cell Cycle Progression and Suppressing Apoptotic Cell DeathKyosuke Habu, Yosuke Matsuoka, Hiromi Hiyoshi, et al.
Molecular Cell|February 4, 2018
SLFN11 Blocks Stressed Replication Forks Independently of ATRJunko Murai, Sai-Wen Tang, Elisabetta Leo, et al.
Pageof 8